Generic Liraglutide manufactured by Novo Nordisk who is also the manufacturer of reference product
Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes
Trials using around 1,200mg/day in divided doses showed modest but consistent improvements in memory and executive function among patients with mild cognitive impairment, Alzheimers, or post-stroke deficits.32 Some reviews also note benefits for mood symptoms (apathy, anxiety) alongside cognition.32 For healthy individuals, the benefits are more nuanced
Indian J Otolaryngol Head Neck Surg 76:110 Pham TNM, Jeong SY, Kim DH, Park YH, Lee JS, Lee KW, Moon IS, Choung SY, Kim SH, Kang TH (2020) Protective mechanisms of avocado oil extract against ototoxicity
Homocysteine Testing The Homocysteine test measures the amount of homocysteine in the bloodstream
Cagrilintide's amylin mechanism (different pathway) How cagrilintide works: Amylin receptor agonist Long-acting weekly injection Investigational (not FDA approved) Different receptors than GIP/GLP-1 Amylin pathway effects: Very strong gastric emptying delay (stronger than GLP-1) Central appetite suppression (area postrema) Reduces meal frequency Suppresses glucagon Enhances satiety Cagrilintide monotherapy results: 10-12% average body weight loss Significant GI side effects (stronger gastric slowing) Currently in Phase 3 trials Not yet available pharmaceutically See our cagrilintide weight loss , cagrilintide dosing , and cagrilintide and semaglutide guides